Company Filing History:
Years Active: 1995-1998
Title: Gregory Lynn Garrison: Innovator in Antiarrhythmic Agents
Introduction
Gregory Lynn Garrison is a notable inventor based in Chelmsford, MA (US). He has made significant contributions to the field of pharmacology, particularly in the development of antiarrhythmic agents. With a total of 2 patents, Garrison's work has the potential to impact medical treatments significantly.
Latest Patents
Garrison's latest patents include N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo-[3.3.1]nonanes. These compounds are disclosed as multiclass antiarrhythmic agents. The general formula for these derivatives includes specific configurations where Q=S, Z=CH₂, and Y represents an N-acyl or N-alkyl group. His research focuses on the therapeutic applications of these compounds in treating arrhythmias.
Career Highlights
Garrison is affiliated with Oklahoma State University, where he continues to advance his research in pharmacology. His academic background and ongoing projects contribute to the understanding and development of new medical therapies.
Collaborations
Some of Garrison's notable coworkers include Kenneth D Berlin and Subbiah Sangiah. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Gregory Lynn Garrison's work in the development of antiarrhythmic agents showcases his dedication to advancing medical science. His patents reflect a commitment to improving healthcare outcomes through innovative research.